York Structural Biology Laboratory, Department of Chemistry, University of York , Heslington, York YO10 5YW, United Kingdom.
J Phys Chem B. 2014 Sep 4;118(35):10515-24. doi: 10.1021/jp505869m. Epub 2014 Aug 21.
Drug molecules with low aqueous solubility can be solubilized by a class of cosolvents, known as hydrotropes. Their action has often been explained by an analogy with micelle formation, which exhibits critical micelle concentration (CMC). Indeed, hydrotropes also exhibit "minimum hydrotrope concentration" (MHC), a threshold concentration for solubilization. However, MHC is observed even for nonaggregating monomeric hydrotropes (such as urea); this raises questions over the validity of this analogy. Here we clarify the effect of micellization on hydrotropy, as well as the origin of MHC when micellization is not accompanied. On the basis of the rigorous Kirkwood-Buff (KB) theory of solutions, we show that (i) micellar hydrotropy is explained also from preferential drug-hydrotrope interaction; (ii) yet micelle formation reduces solubilization effeciency per hydrotrope molecule; (iii) MHC is caused by hydrotrope-hydrotrope self-association induced by the solute (drug) molecule; and (iv) MHC is prevented by hydrotrope self-aggregation in the bulk solution. We thus need a departure from the traditional view; the structure of hydrotrope-water mixture around the drug molecule, not the structure of the aqueous hydrotrope solutions in the bulk phase, is the true key toward understanding the origin of MHC.
具有低水溶性的药物分子可以通过一类称为增溶剂的共溶剂来增溶。它们的作用经常通过与胶束形成的类比来解释,胶束形成表现出临界胶束浓度(CMC)。事实上,增溶剂也表现出“最小增溶剂浓度”(MHC),这是增溶的阈值浓度。然而,即使是非聚集的单体增溶剂(如尿素)也会观察到 MHC;这引发了对这种类比有效性的质疑。在这里,我们澄清了胶束化对增溶的影响,以及在没有胶束化伴随的情况下 MHC 的起源。基于严格的 Kirkwood-Buff (KB) 溶液理论,我们表明:(i) 胶束增溶也可以通过药物-增溶剂的优先相互作用来解释;(ii) 然而,胶束形成会降低每个增溶剂分子的增溶效率;(iii) MHC 是由溶质(药物)分子引起的增溶剂自缔合引起的;(iv) 增溶剂在本体溶液中的自聚集可以防止 MHC。因此,我们需要背离传统观点;理解 MHC 起源的真正关键是药物分子周围增溶剂-水混合物的结构,而不是本体相中水性增溶剂溶液的结构。